Metastatic non-small cell lung cancer management: novel targets and recent clinical advances

Area of Science:

• Oncology
• Molecular Biology
• Clinical Medicine

Background:

• Lung cancer is the leading cause of cancer mortality globally.
• Non-small cell lung cancer (NSCLC) is the most prevalent subtype.
• NSCLC exhibits significant molecular heterogeneity, impacting treatment strategies.

Purpose of the Study:

• To highlight recent advancements in targeted therapy for NSCLC.
• To discuss the evolving role of maintenance treatment in NSCLC management.
• To underscore the importance of molecular heterogeneity in guiding NSCLC clinical trials.

Main Methods:

• Review of current literature on NSCLC targeted therapies.
• Analysis of recent clinical trial data on maintenance treatments.
• Focus on molecular profiling and its impact on treatment selection.

Main Results:

• Targeted therapies are increasingly effective for specific molecular alterations in NSCLC.
• Maintenance therapy demonstrates improved outcomes in select NSCLC patient populations.
• Discovery of new actionable mutations in both adenocarcinoma and squamous cell NSCLC.

Conclusions:

• Molecular heterogeneity in NSCLC necessitates personalized treatment approaches.
• Targeted therapies and maintenance treatments represent key shifts in NSCLC management.
• Continued research into oncogene-addicted pathways is crucial for improving NSCLC outcomes.